Methylprednisolone acetate is a synthetic glucocorticoid, specifically the 21-acetate ester of methylprednisolone. It is a white to off-white crystalline powder that is practically insoluble in water but soluble in organic solvents like acetone and chloroform. As a prodrug, it is hydrolyzed in vivo to release the active methylprednisolone. Its primary application is as an active pharmaceutical ingredient (API) in injectable formulations for potent anti-inflammatory and immunosuppressive therapy. It is widely used to treat a variety of conditions, including severe allergic reactions, dermatological diseases, rheumatoid arthritis, and to manage inflammation in ophthalmic and intra-articular settings. It also plays a key role in endocrine therapy, such as in hormone replacement for adrenal insufficiency. The acetate ester form provides a prolonged duration of action due to its slower release from the injection site. Handling requires caution as it is a potent steroid. It is subject to significant regulatory controls as a prescription drug. Common side effects with systemic use are consistent with corticosteroid therapy and may include hyperglycemia, immunosuppression, and fluid retention.